Why the study?
Is flow-mediated endothelium-dependent vasodilatation impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal TSH levels?
Is flow-mediated endothelium-dependent vasodilatation impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal TSH levels?
Answers are grounded in this paper and cite their sources.
Endothelial function is impaired not only in clinical hypothyroidism but also in subjects with high-normal TSH levels, suggesting an early increased risk for atherosclerosis.
Patients with hypothyroidism are considered to have an increased risk of developing atherosclerosis; because endothelial dysfunction is an early sign of atherosclerosis, we investigated whether endothelial dysfunction is present in patients with hypothyroidism. Thirty-five subjects with various TSH levels were investigated by high-resolution ultrasound imaging of the brachial artery to assess endothelial and smooth muscle responses. Flow-mediated, endothelium-dependent vasodilatation was significantly higher in subjects with TSH 0.4-2 microIU/mL (11.8 +/- 2.7%), compared with subjects with TSH 2.01-4 microIU/mL (6.8 +/- 2.9%), 4.01-10 microIU/mL (5.2 +/- 6.3%) and >10 microIU/mL (4.0 +/- 4.4%); TSH levels correlated inversely to endothelium-dependent dilatation. Thus, flow-mediated vasodilatation, a marker of endothelial function, is impaired not only in patients with mild hypothyroidism but also in subjects with "high-normal" serum TSH levels (ie, 2.01-4.0 microIU/mL) that may be characterized as possibly abnormal.
No takes yet. Share an insight, caveat, or question.
Lekakis et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: